Combination of PI3-kinase and PARP inhibitors may offer new treatment option for triple-negative breast cancers

The simultaneous inhibition of two separate and seemingly unrelated pathways could potentially provide an effective treatment for women with triple-negative breast cancer, according to results of two new studies.